Reports for SUN PHARMACEUTICAL INDUSTRIES LIMITED
Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Totals |
||
Shortage reports |
6 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 6 (100%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
5 (83%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CEQUA | 0.09% | SOLUTION | Resolved | 2021-11-15 | 2022-01-19 | 149218 |
CEQUA | 0.09% | SOLUTION | Resolved | 2022-06-27 | 2022-07-05 | 163527 |
ABSORICA LD | 8MG | CAPSULE | Resolved | 2023-10-10 | 2023-11-21 | 206725 |
ABSORICA LD | 16MG | CAPSULE | Resolved | 2023-10-10 | 2023-11-21 | 206731 |
ABSORICA LD | 24MG | CAPSULE | Resolved | 2023-10-10 | 2023-11-21 | 206728 |
ABSORICA LD | 32MG | CAPSULE | Resolved | 2023-10-10 | 2023-11-21 | 206734 |
Showing 1 to 6 of 6
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0